David Jin

CIK: 0001930732

Transaction Breakdown

Open Market Buys (P)1 (11.1%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)8 (88.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

FBIO

Fortress Biotech, Inc.

Officer

MBIO

MUSTANG BIO, INC.

Director

ATXI

AVENUE THERAPEUTICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

FBIO
Fortress Biotech, Inc.
Oct 1, 2026
Award(A)
Direct
1.2K shares at avg. $1.82$2K
FBIO
Fortress Biotech, Inc.
Jun 22, 2026
Award(A)
Direct
400K shares-
FBIO
Fortress Biotech, Inc.
Apr 1, 2026
Award(A)
Direct
3K shares at avg. $2.18$6K
MBIO
MUSTANG BIO, INC.
Dec 30, 2025
Purchase(P)
Direct
247 shares at avg. $0.96$237.614
FBIO
Fortress Biotech, Inc.
Oct 1, 2025
Award(A)
Direct
2.7K shares at avg. $1.31$4K
FBIO
Fortress Biotech, Inc.
Apr 1, 2025
Award(A)
Direct
5K shares at avg. $1.22$6K
FBIO
Fortress Biotech, Inc.
Dec 19, 2024
Award(A)
Direct
1M shares-
FBIO
Fortress Biotech, Inc.
Oct 1, 2024
Award(A)
Direct
2.6K shares at avg. $1.23$3K
ATXI
AVENUE THERAPEUTICS, INC.
Sep 23, 2024
Award(A)
Direct
65K shares-

		Type	Shares	Price		Ownership
Oct 1, 2026	FBIO Fortress Biotech, Inc.	Award(A)	1,190	$1.82	$2,165	Direct
Jun 22, 2026	FBIO Fortress Biotech, Inc.	Award(A)	400,000	-	$0	Direct
Apr 1, 2026	FBIO Fortress Biotech, Inc.	Award(A)	2,967	$2.18	$6,456	Direct
Dec 30, 2025	MBIO MUSTANG BIO, INC.	Purchase(P)	247	$0.96	$238	Direct
Oct 1, 2025	FBIO Fortress Biotech, Inc.	Award(A)	2,711	$1.31	$3,549	Direct
Apr 1, 2025	FBIO Fortress Biotech, Inc.	Award(A)	5,000	$1.22	$6,078	Direct
Dec 19, 2024	FBIO Fortress Biotech, Inc.	Award(A)	1,000,000	-	$0	Direct
Oct 1, 2024	FBIO Fortress Biotech, Inc.	Award(A)	2,625	$1.23	$3,224	Direct
Sep 23, 2024	ATXI AVENUE THERAPEUTICS, INC.	Award(A)	65,000	-	$0	Direct

1-9 of 9 transactions

About Jin David

Jin David (SEC CIK 0001930732) files insider reports with the SEC as Chief Financial Officer of Fortress Biotech, Inc. (FBIO), Director of MUSTANG BIO, INC. (MBIO) and Interim PFO and COO of AVENUE THERAPEUTICS, INC. (ATXI).

Signal8 holds 10 ownership filings by Jin David (1 Form 3, 9 Form 4), filed between Sep 25, 2024 and Oct 1, 2026. Those filings report 9 transactions, from Sep 23, 2024 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Jin David's filings is in BAY HARBOR ISLANDS, FL.

Recent filings by Jin David

Oct 1, 2026: Grant or award of FBIO shares (Form 4, code A).
Jun 22, 2026: Grant or award of FBIO shares (Form 4, code A).
Apr 1, 2026: Grant or award of FBIO shares (Form 4, code A).
Dec 30, 2025: Open-market purchase of MBIO shares (Form 4, code P).
Oct 1, 2025: Grant or award of FBIO shares (Form 4, code A).

Other insiders filing for Fortress Biotech, Inc. (FBIO)

ROSENWALD LINDSAY A MD, PRESIDENT, CEO & CHAIRMAN
WEISS MICHAEL S, Executive Vice Chairman
Klein Dov, Director
Harvey Jimmie, Director
Lorenz Kevin, Director
Hoenlein Malcolm, Director

How to read Form 4 transaction codes